Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant.
GvHD
HPSE
rs4364254
rs4693608
single nucleotide polymorphisms
Journal
International journal of laboratory hematology
ISSN: 1751-553X
Titre abrégé: Int J Lab Hematol
Pays: England
ID NLM: 101300213
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
28
04
2023
accepted:
10
08
2023
medline:
17
11
2023
pubmed:
30
8
2023
entrez:
30
8
2023
Statut:
ppublish
Résumé
The heparanase (HPSE) gene is highly polymorphic, but only a minority of its single nucleotide polymorphisms (SNPs) have been studied. Among these, rs4693608 and rs4364254 SNPs are closely associated with mRNA expression and HPSE protein levels in healthy subjects. Given the association between HPSE and inflammatory response, we aimed to evaluate whether HPSE rs4693608 and rs4364254 SNPs could have an impact on graft-versus-host disease after allogeneic stem cell transplants (HSCT). A total of 228 consecutive patients who underwent HSCT at our center between 2005 and 2018 were included. The rs4693608 SNP was identified by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis, while the rs4364254 was detected by allele-specific amplification. The recipient-donor discrepancy for rs4364254 HPSE SNP was significantly associated with grade II-IV aGvHD (HR 1.75, p = 0.03). Patients were stratified into risk groups as follows: low-risk group (LDR) including TT-TT, TT-CT, CT-TT, CC-CC; high-risk group (HDR) including CC-CT, CC-TT, CT-CC, CT-CT, TT-CC. Day 100 cumulative incidence of grade II-IV aGvHD was 23.4% in the LDR group and 41.4% in the HDR group (p = 0.01). One-year cumulative incidence of moderate/severe cGvHD was 42.6% in the LDR group and 58.6% in the HDR group (p = 0.04). Independent variables for moderate/severe cGvHD in patients who received myeloablative conditioning included donor rs4693608 SNP (GA/AA vs. GG: HR 6.86, p = 0.008), rs4693608-rs4364254 SNP combination in recipient (HR/MR vs. LR: HR 3.67, p = 0.01), and previous grade II-IV aGvHD (HR 3.28, p = 0.0005). Finally, donors with rs4364254 SNP CC conferred increased transplant-related mortality (TRM) (39.1% vs. 25%, p = 0.03) and decreased graft-relapse free survival (GRFS) (23.5% vs. 34.4%, p = 0.04) compared with CT or TT genotypes. The differences in incidence of GvHD according to recipient-donor genotype combinations suggests a possible role for rs4364254 HPSE SNP in predicting GvHD. A high level of HPSE, particularly linked to CC genotype of rs4364254 SNP may promote alloreactive T lymphocytes activation and migration toward target organs.
Substances chimiques
heparanase
EC 3.2.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
935-944Subventions
Organisme : Università Cattolica del Sacro Cuore
Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Rivara S, Milazzo FM, Giannini G. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases. Future Med Chem. 2016;8:647-680. doi:10.4155/fmc-2016-0012
Aalkjaer C, Boedtkjer DB. Getting neointimal: the emergence of heparanase into the vascular matrix. Circulation Res. 2009;104:277-279. doi:10.1161/CIRCRESAHA.108.192625
Sasaki N, Higashi N, Taka T, Nakajima M, Irimura T. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate. J Immunol. 2004;172:3830-3835. doi:10.4049/jimmunol.172.6.3830
Goodall KJ, Poon IK, Phipps S, Hulett MD. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4. PloS One. 2014;9:e109596. doi:10.1371/journal.pone.0109596
Goldberg R, Meirovitz A, Hirshoren N, et al. Versatile role of heparanase in inflammation. Matrix Biol. 2013;32:234-240. doi:10.1016/j.matbio.2013.02.008
Li JP, Vlodavsky I. Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb Haemost. 2009;102:823-828. doi:10.1160/TH09-02-0091
Zhang X, Wang B, Li JP. Implications of heparan sulfate and heparanase in neuroinflammation. Matrix Biol. 2014;35:174-181. doi:10.1016/j.matbio.2013.12.009
Doviner V, Maly B, Kaplan V, et al. Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence. Mod Pathol. 2006;19:878-888. doi:10.1038/modpathol.3800603
Lerner I, Hermano E, Zcharia E, et al. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. J Clin Invest. 2011;121:1709-1721. doi:10.1172/JCI43792
Waterman M, Ben-Izhak O, Eliakim R, Groisman G, Vlodavsky I, Ilan N. Heparanase upregulation by colonic epithelium in inflammatory bowel disease. Mod Pathol. 2007;20:8-14. doi:10.1038/modpathol.3800710
Li RW, Freeman C, Yu D, et al. Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis. Arthritis Rheum. 2008;58:1590-1600. doi:10.1002/art.23489
Ostrovsky O, Korostishevsky M, Levite I, et al. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies. Leukemia. 2007;21(11):2296-2303. doi:10.1038/sj.leu.2404821
Ostrovsky O, Korostishevsky M, Shafat I, et al. Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation. J Leukoc Biol. 2009;86(2):445-455. doi:10.1189/jlb.1208735
Ostrovsky O, Shimoni A, Rand A, Vlodavsky I, Nagler A. Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors. Blood. 2010;115(11):2319-2328. doi:10.1182/blood-2009-08-236455
Ostrovsky O, Korostishevsky M, Levite I, et al. Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel. Acta Haematol. 2007;117:57-64. doi:10.1159/000096790
Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium. Blood Marrow Transplant. 2016;22:4-10. doi:10.1016/j.bbmt.2015.09.001
Jagasia MJ, Greinix HT, Arora M, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2015;21(3):389-401.e1. doi:10.1016/j.bbmt.2014.12.001
Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol. 2006;38:2018-2039. doi:10.1016/j.biocel.2006.06.004
Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta. 2001;1471(3):M99-M108. doi:10.1016/s0304-419x(01)00017-8
Gohji K, Okamoto M, Kitazawa S, et al. Heparanase protein and gene expression in bladder cancer. J Urol. 2001;166(4):1286-1290.
Boyango I, Barash U, Naroditsky I, et al. Heparanase cooperates with Ras to drive breast and skin tumorigenesis. Cancer Res. 2014;74:4504-4514. doi:10.1158/0008-5472.CAN-13-2962
Ma XM, Shen ZH, Liu ZY, et al. Heparanase promotes human gastric cancer cells migration and invasion by increasing Src and p38 phosphorylation expression. Int J Clin Exp Pathol. 2014;7(9):5609-5621.
Vlodavsky I, Singh P, Boyango I, et al. Heparanase: from basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat. 2016;29:54-75. doi:10.1016/j.drup.2016.10.001
Secchi MF, Masola V, Zaza G, Lupo A, Gambaro G, Onisto M. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. Biomol Concepts. 2015;6(5-6):415-421. doi:10.1515/bmc-2015-0021
Fux L, Feibish N, Cohen-Kaplan V, et al. Structure-function approach identifies a C-terminal domain that mediates heparanase signaling. Cancer Res. 2009;69(5):1758-1767. doi:10.1158/0008-5472.CAN-08-1837
He YQ, Sutcliffe EL, Bunting KL, et al. The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes. Transcription. 2012;3(3):130-145. doi:10.4161/trns.19998
Bitan M, Polliack A, Zecchina G, et al. Heparanase expression in human leukemias is restricted to acute myeloid leukemias. Exp Hemat. 2002;30:34-41. doi:10.1016/s0301-472x(01)00766-4
Ostrovsky O, Shimoni A, Baryakh P, et al. Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP. J Leukoc Biol. 2014;95(4):677-688. doi:10.1189/jlb.0313147
Seifert C, Wittig S, Arndt C, Gruhn B. Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2015;141(5):877-885. doi:10.1007/s00432-014-1857-2
Benimetskaya I, Wu S, Voskresensky AM, et al. Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease. Blood. 2008;112(10):4343-4352. doi:10.1182/blood-2008-04-149682
Corbacioglu S, Cesaro S, Faraci M, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet. 2012;379(9823):1301-1309. doi:10.1016/S0140-6736(11)61938-7
Andersen NF, Vogel U, Klausen TW, et al. Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival. Eur J Haematol. 2015;94(1):60-66. doi:10.1111/ejh.12401
Ostrovsky O, Baryakh P, Morgulis Y, et al. The HPSE gene insulator-a novel regulatory element that affects Heparanase expression, stem cell mobilization, and the risk of acute graft versus host disease. Cell. 2021;23(10):2523. doi:10.3390/cells10102523
Mueckenhausen R, Föll J, Kleinschmidt K, et al. Heparanase wildtype is associated with a reduced incidence of transplant-associated systemic vasculopathies. Hematol Oncol Stem Cell Ther. 2021;22:00108.
Ostrovsky O, Vlodavsky I, Nagler A. Mechanism of HPSE gene SNPs function: from Normal processes to inflammation, Cancerogenesis and tumor progression. Adv Exp Med Biol. 2020;1221:231-249. doi:10.1007/978-3-030-34521-1_8
Bitan M, Weiss L, Zeira M, et al. Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation. PloS One. 2010;5(4):e10135. doi:10.1371/journal.pone.0010135